These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15598747)

  • 1. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.
    Rong R; Tang X; Gutmann DH; Ye K
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18200-5. PubMed ID: 15598747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of merlin regulates its stability and tumor suppressive activity.
    Ye K
    Cell Adh Migr; 2007; 1(4):196-8. PubMed ID: 19262146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
    James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
    Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate.
    Sun CX; Haipek C; Scoles DR; Pulst SM; Giovannini M; Komada M; Gutmann DH
    Hum Mol Genet; 2002 Dec; 11(25):3167-78. PubMed ID: 12444101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.
    Cui Y; Groth S; Troutman S; Carlstedt A; Sperka T; Riecken LB; Kissil JL; Jin H; Morrison H
    Oncogene; 2019 Sep; 38(36):6370-6381. PubMed ID: 31312020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.
    Tang X; Jang SW; Wang X; Liu Z; Bahr SM; Sun SY; Brat D; Gutmann DH; Ye K
    Nat Cell Biol; 2007 Oct; 9(10):1199-207. PubMed ID: 17891137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The merlin interacting proteins reveal multiple targets for NF2 therapy.
    Scoles DR
    Biochim Biophys Acta; 2008 Jan; 1785(1):32-54. PubMed ID: 17980164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.
    Lee H; Kim D; Dan HC; Wu EL; Gritsko TM; Cao C; Nicosia SV; Golemis EA; Liu W; Coppola D; Brem SS; Testa JR; Cheng JQ
    Mol Cell Biol; 2007 Mar; 27(6):2103-19. PubMed ID: 17210637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.
    Lepont P; Stickney JT; Foster LA; Meng JJ; Hennigan RF; Ip W
    Mutat Res; 2008 Jan; 637(1-2):142-51. PubMed ID: 17868749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoinositol lipids bind to phosphatidylinositol 3 (PI3)-kinase enhancer GTPase and mediate its stimulatory effect on PI3-kinase and Akt signalings.
    Hu Y; Liu Z; Ye K
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16853-8. PubMed ID: 16263930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.
    Wong HK; Shimizu A; Kirkpatrick ND; Garkavtsev I; Chan AW; di Tomaso E; Klagsbrun M; Jain RK
    Neoplasia; 2012 Feb; 14(2):84-94. PubMed ID: 22431917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression.
    Xiao GH; Gallagher R; Shetler J; Skele K; Altomare DA; Pestell RG; Jhanwar S; Testa JR
    Mol Cell Biol; 2005 Mar; 25(6):2384-94. PubMed ID: 15743831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
    Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K
    Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
    Bashour AM; Meng JJ; Ip W; MacCollin M; Ratner N
    Mol Cell Biol; 2002 Feb; 22(4):1150-7. PubMed ID: 11809806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.
    Li W; You L; Cooper J; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
    Cell; 2010 Feb; 140(4):477-90. PubMed ID: 20178741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
    Laulajainen M; Muranen T; Carpén O; Grönholm M
    Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
    Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P
    Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merlin sumoylation is required for its tumor suppressor activity.
    Qi Q; Liu X; Brat DJ; Ye K
    Oncogene; 2014 Oct; 33(41):4893-903. PubMed ID: 24166499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1).
    Li W; Giancotti FG
    Cell Cycle; 2010 Nov; 9(22):4433-6. PubMed ID: 21084862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt phosphorylation of merlin enhances its binding to phosphatidylinositols and inhibits the tumor-suppressive activities of merlin.
    Okada M; Wang Y; Jang SW; Tang X; Neri LM; Ye K
    Cancer Res; 2009 May; 69(9):4043-51. PubMed ID: 19351837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.